ロード中...
Decreased expression of MT1E is a potential biomarker of prostate cancer progression
Differentiation of indolent and aggressive prostate carcinoma (PCa) at the time of diagnosis is currently one of the major challenges. This study aimed at identification of prognostic biomarkers to aid in predicting biochemical recurrence (BCR) of the disease. Microarray-based gene expression profil...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5617458/ https://ncbi.nlm.nih.gov/pubmed/28977898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18683 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|